7th Eurasian Hematology Oncology Summit
2020 Updates on Frontline AML: Does Midostaurin+Chemo Reduce the Risk of Death in FLT3-Mutated Disease? Can We Prolong OS and Achieve CR With CPX-351? Is There a Way to Avoid Apoptosis With Ven+FLAI?
Comments 0
Login to view comments.
Click here to Login
